TrialBMC ophthalmology2022

Outcomes of near confluent laser versus combined less dense laser and bevacizumab treatment of prethreshold ROP Type 1 Zone 2: a randomized controlled trial.

Ehsan Namvar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.